GlassScriptPhysician profile
Michael A Pritchett
NPI 1023055761
$1,321,746.93
in general payments reported to CMS, 2019-2025
69 companies · $112K in 2025
The $112K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99K · 2020: $169K · 2021: $282K · 2022: $340K · 2023: $125K · 2024: $195K · 2025: $112K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $281K · Consulting Fee: $63K · Travel and Lodging: $45K · Education: $32K · Food and Beverage: $12K · Gift: $43.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $280,805.00 |
| Consulting Fee | $63,297.50 |
| Travel and Lodging | $44,644.92 |
| Education | $31,678.99 |
| Food and Beverage | $11,759.02 |
| Gift | $43.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,037,708.87 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System, Ion |
| Astrazeneca Pharmaceuticals LP | $47,804.36 | 2019-2025 | Tagrisso, Tezspire, Airsupra |
| Ambu A/S | $41,554.54 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $32,166.85 | 2019-2024 | Opsumit, Uptravi |
| Galvanize Therapeutics, INC | $30,388.66 | 2022-2025 | Aliya System |
| Ethicon Endo-Surgery INC. | $20,454.55 | 2019-2023 | |
| Covidien LP | $17,019.85 | 2019-2020 | |
| Serpex Medical INC | $16,000.00 | 2024-2025 | |
| Ethicon INC. | $13,453.15 | 2019-2023 | Monarch Platform |
| United Therapeutics Corporation | $10,315.08 | 2019-2022 | |
| Medtronic, INC. | $9,735.63 | 2021-2024 | Illumisite |
| Pfizer INC. | $7,159.61 | 2020-2025 | |
| Ethicon US, LLC | $6,857.05 | 2019-2022 | |
| Healthmyne, INC. | $5,896.94 | 2019-2020 | |
| Medical Device Business Services, INC. | $5,342.20 | 2019 |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,520.35 | 2019-2022 | |
| Cook Incorporated | $4,377.50 | 2025 | Echotip Procore |
| Siemens Medical Solutions USA, INC. | $2,597.37 | 2024-2025 | Cios Spin |
| Philips North America LLC | $970.35 | 2019-2025 | (Bi2) Igt Systems Undivided, Azurion 7 M20, (9547) Igt Systems Undivided |
| Glaxosmithkline, LLC. | $830.47 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Noah Medical Corporation | $567.28 | 2023-2025 | Galaxy |
| Grifols USA, LLC | $517.46 | 2019-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $465.50 | 2019-2025 | Keytruda, Winrevair, Keytruda Qlex |
| Takeda Pharmaceuticals U.S.A., INC. | $455.31 | 2019-2025 | Glassia, Iclusig, Fruzaqla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $379.60 | 2019-2024 | Ofev |
| Insmed, INC. | $331.34 | 2021-2025 | Arikayce |
| Mylan Specialty L.P. | $307.46 | 2019-2023 | Yupelri |
| Auris Health, INC. | $261.55 | 2019 | |
| Genzyme Corporation | $234.15 | 2019-2025 | |
| Amgen INC. | $223.35 | 2022-2025 | Tezspire, Tavneos, Lumakras |
| Genentech USA, INC. | $199.44 | 2019-2024 | Alecensa, Tecentriq, Rozlytrek |
| Pulmonx Corporation | $195.92 | 2021-2023 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Seagen INC. | $178.34 | 2021-2023 | Padcev, Tukysa |
| Regeneron Healthcare Solutions, INC. | $176.08 | 2019-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $175.38 | 2022-2025 | Acthar |
| Janssen Research & Development, LLC | $172.46 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $168.51 | 2020-2025 | |
| Servier Pharmaceuticals LLC | $156.27 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $131.61 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $107.45 | 2019-2020 | |
| Olympus America INC. | $90.28 | 2019 | |
| Daiichi Sankyo INC. | $83.59 | 2019-2024 | Enhertu |
| Shire North American Group INC | $79.01 | 2019 | |
| Viatris Specialty LLC | $74.08 | 2025 | Yupelri |
| Celgene Corporation | $72.10 | 2019-2022 | |
| Lilly USA, LLC | $69.28 | 2019-2025 | Jaypirca, Retevmo, Verzenio |
| Ani Pharmaceuticals, INC. | $62.83 | 2025 | Purified Cortrophin Gel |
| Imbio INC. | $56.50 | 2023 | Imbio Lung Density Analysis |
| Eisai INC. | $56.08 | 2022-2024 | |
| Vifor Pharma, INC. | $49.18 | 2024-2025 | Zemaira |
| Cook Medical LLC | $41.76 | 2023 | Echotip Procore |
| Aveo Pharmaceuticals, INC. | $41.43 | 2024-2025 | |
| Advanced Respiratory, INC | $41.32 | 2021 | |
| Baxter Healthcare | $40.36 | 2022 | |
| Novartis Pharmaceuticals Corporation | $37.86 | 2019-2020 | |
| Csl Behring | $35.15 | 2019 | |
| Gilead Sciences, INC. | $34.30 | 2019-2021 | |
| Exelixis INC. | $34.27 | 2021-2024 | Cabometyx |
| Geron Corporation | $28.09 | 2025 | Rytelo |
| Beigene USA, INC. | $22.69 | 2023 | Brukinsa |
| Irhythm Technologies, INC. | $21.43 | 2024 | Zio Xt Patch, Zio Monitor |
| Abbott Laboratories | $21.41 | 2025 | Cardiomems |
| Verona Pharma, INC. | $18.41 | 2025 | Ohtuvayre |
| Janssen Biotech, INC. | $17.28 | 2025 | Rybrevant |
| Incyte Corporation | $16.74 | 2024 | Monjuvi |
| Veran Medical Technologies, INC. | $15.99 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $14.20 | 2024 | Lumryz |
| La Jolla Pharmaceutical Company | $13.47 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pritchett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.